ST. LOUIS (Oct. 17, 2003) – ZeaVision, L.L.C., a nutraceutical company with a focus in eye health, announces Mr. Terry B. Hatfield as president. Hatfield brings to ZeaVision over 30 years experience in the food and nutraceutical business. Most recently, Hatfield has been involved with M&A activities and consulting. Previously, he held a number of senior executive positions with Ralston Purina and DuPont in Protein Technologies International division, where his last position was co-president, responsible for sales, marketing, application technology and manufacturing.
In addition to his responsibilities as president, Hatfield will be a key member of the executive committee, joining the chairman and CEO, Dennis L. Gierhart, Ph.D., and vice chairman, Steven N. Frank.
“We are very excited about having Terry on our team. He brings a wealth of experience to ZeaVision and provides us with the expertise to bring our company to the next level. The addition of Terry will allow all of us to focus more on the key strategic issues that will lay the groundwork for continued growth and success,” said Gierhart.
Hatfield, 55, holds a B.A. in chemistry from the University of Louisville, as well as numerous postgraduate and professional studies in general management.
“I am truly excited about joining the ZeaVision team. This is an outstanding opportunity with an organization that has tremendous potential with a patent-protected product that offers significant health benefits. I am looking forward to working with the talented team that ZeaVision has assembled.”
About ZeaVision, L.L.C.
St. Louis-based ZeaVision L.L.C. (www.zeavison.com), an emerging nutraceutical company, developed and markets ZeaVision, a dietary supplement containing zeaxanthin and formulated to help prevent and/or impede the progression of macular degeneration. The company holds multiple patents on the ZeaVison formula, which is available without a prescription in a 10-milligram or 3-milligram supplement.